(R)-1-(3,4-Difluorophenyl)ethanamine hydrochloride, 95.0%, 100mg

2,5-Dioxopyrrolidin-1-yl heptanoate, 95%, 100mg

Methyl 2-oxo-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)acetate, 95.0%, 250mg

GlcNAc beta(1-4)[Fuc alpha(1-6)]GlcNAc>98.0%(HPLC)2mg

(R)-Bis((R)-1-(naphthalen-1-yl)ethyl)amine hydrochloride, 97%, 250mg

Soluzione di solfuro di ammonio, 20%, puro, 100 ml, sacchetto di plastica.

2-Chloro-5-nitrocinnamic Acid>97.0%(T)25g

2-chloro-5-iodo-4-methylpyridine-3-carbonitrile, 97%, 5g

2-Methylbutyl (1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)carbamate, 95.0%, 100mg

1-N-Boc-Piperidine-3-ethanol, 98.0%, 5g

(1S,2S)-2-(Benzylamino)cyclohexanol, 95.0%, 5g

5-(2-Methoxyethyl)-1,3,4-thiadiazol-2-amine, 95%, 500mg

5-hydroxy-4-phenyl-2,3-dihydro-1,2-oxazol-3-one, 95.0%, 250mg